News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Nanosphere antiplatelet gene test “not approvable”
You may also be interested in...
Senate Panel Details Medtronic Role In Editing Out Negative Study Findings From Journal Article
A Medtronic employee urged leaving out adverse event details in a medical journal article on the firm's InFuse bone graft product, according to a Senate Finance Committee investigatory report.
Luminex Gains Integrated Assay System With $50 Mil. GenturaDx Purchase
Deal will enable integration of Luminex’s MultiCode-RTx technology and assays with GenturaDx’s IDbox fully automated, real-time PCR system.
TCT Late-Breaker: Point-Of-Care Genetic Test Guides Antiplatelet Therapy
Data presented at the Transcatheter Cardiovascular Therapeutics meeting may support rapid, point-of-care genetic testing in tailoring antiplatelet therapy, but clinicians are still not convinced.